References
- Castells S., Inamdar S., Baker R. K., Wallach S. Effect of porcine calcitonin in osteogenesis imperfecta tarda. Pediatrics 1972; 80: 757–762
- Christiansen C., Rodbro P. Long-term reproducibility of bone mineral content measurements. Scand. J. clin. Lab. Invest. 1977; 37: 321–323
- Christiansen C, Rodbro P., Jensen H. Bone mineral content in the forearm measured by photon absorptiometry. Scand. J. clin. Lab. Invest. 1975; 35: 323–330
- Dietrich F. M., Hunziker W. H., Fischer J. A. Synthetic human calcitonin: Analysis of antibodies obtained from various animal species and determination of immunoreactive hormone in human sera. Acta endocr. (Kbh.) 1975; 80: 465–486
- Franchimont P., Heynen G. Parathormone and calcitonin radioimmunoassay in various medical and osteo articular disorders. Masson Inc., New York 1976
- Haddad J. G., Jr., Caldwell J. G. Calcitonin resistance, clinical and immunological studies in subjects with Paget's disease of bone. J. clin. Invest. 1972; 51: 3133–3141
- Kanis J. A., Fitzpatrick K., Strong J. A. Treatment of Paget's disease of bone with porcine calcitonin: clinical and metabolic responses. Quart. J. Med. 1975; 44: 399–413
- Kanis J. A., Heynen G., Walton R. J. Plasma calcitonin in Paget's disease of bone. Clin. Set. 1977; 52: 329–332
- Paterson C. R. Metacarpal morphometry in adults with osteogenesis imperfecta. Brit. med. J. 1978; 1: 213–214
- Pedersen K. O. Calcium in human serum. Biochemical and clinical aspects. Thesis. University of Aarhus. 1973
- Rebel A., Malkani K., Basle M., Bregon C. Calcified tissues. FADL's Forlag, Copenhagen 1975; 114
- Riley F. C., Jowsey J., Brown D. M. Osteogenesis imperfecta: Morphologic and biochemical studies of connective tissue. Pediat. Res. 1973; 9: 757–768
- Rosenberg E., Lang R., Boisseau V., Ro-Janasathit S., Avioli L. V. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta. J. clin. Endocr. 1977; 44: 346–355
- Tashjian A. H., Jr. Immunoassay of thyrocalcitonin. I. The method and its serological specificity. Endocrinology 1969; 84: 140–148
- Wallach S., Chausmer A., Mittleman R. In vivo inhibition of bone resorption by thyrocalcitonin. Endocrinology 1967; 80: 61–64
- Woodhouse N. J. Y., Reiner M., Bordier P., Kalu D. N., Fisher M., Foster G. V., Joplin G. F., Maclntyre I. Human calcitonin in the treatment of Paget's bone disease. Lancet 1971; i: 1139–1143